4.3 Article

Loss of function mutations of BCOR in classical Hodgkin lymphoma

期刊

LEUKEMIA & LYMPHOMA
卷 63, 期 5, 页码 1080-1090

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/10428194.2021.2015587

关键词

Classical Hodgkin lymphoma; microdissection; BCOR; Polycomb; PRC1

资金

  1. FEBS Long-Term Fellowship
  2. Polish Ministry of Science and Higher Education
  3. Wilhelm Sander Stiftung [2018.101.1]
  4. DFG [KU1315/10-1, SFB 1074]
  5. NIH [5R01CA071540]
  6. Minnesota Masonic Charities
  7. University of Minnesota Medical School and Office of the Vice President for Research
  8. NCI [R35 CA220499]
  9. Chemotherapy Foundation
  10. Follicular Lymphoma Consortium
  11. LLS SCOR [7012-16]
  12. LLS TRP [6572-19]
  13. American Society of Hematology Scholar Award
  14. European Union [952304]

向作者/读者索取更多资源

Loss of BCOR may play a role in the pathogenesis of cHL and the homeostasis of GC-B cells.
BCOR is a component of a variant Polycomb repressive complex 1 (PRC1.1). PRC1 and PRC2 complexes together constitute a major gene regulatory system critical for appropriate cellular differentiation. The gene is upregulated in germinal center (GC) B cells and mutated in a number of hematologic malignancies. We report BCOR inactivating alterations in 4/7 classic Hodgkin lymphoma (cHL) cell lines, subclonal somatic mutations in Hodgkin and Reed-Sternberg (HRS) cells of 4/10 cHL cases, and deletions in HRS cells of 7/17 primary cHL cases. In mice, conditional loss of Bcor driven by AID-Cre in GC B cells resulted in gene expression changes of 46 genes (>2-fold) including upregulated Lef1 that encodes a transcription factor responsible for establishing T-cell identity and Il9r (interleukin-9 receptor), an important member of the cytokine network in cHL. Our findings suggest a role for BCOR loss in cHL pathogenesis and GC-B cell homeostasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据